Claim
In the Alliance A071801 randomized phase 3 trial of 242 patients with resected large brain metastases, three-to-five-session radiosurgery improved one-year surgical-bed control and median survival versus single-session radiosurgery without significant overall adverse-event differences.
33 words; atomic claims are usually under 25a conjunction joins clauses that may be separately evaluableTopics
Medicine · 1efd24fe Health · 1efd24fe
Assessment
Supported
Main unresolved issue: 3 counted evidence items have no independence review; repeats of one origin may be counted as several coverage:3d0f1151-a657-8336-9af5-c642c3599d58
Not yet independently audited.Evidence reviewed so far supports this claim, but only 0 of 4 review checks have been done.A quoted passage from healio.com and newswise.com was not found on the page when Galedra fetched it.
Why?
Strongest counted support: The trial report gives 242 randomized patients, 87% versus 81% one-year surgical-bed control, and 29 versus 20 months median survival. weight 1.800000 evidence
Suppressed as dependent: The passage directly reports the 242-patient trial, improved one-year surgical-bed control, and median survival difference.
Review gaps: qualifiers reviewed, opposing search done, independence reviewed, primary source reviewed
What would most change this: One independent, direct measurement that contradicts this claim would move it from Supported to Leans supported.
Your view
Registered views
Nobody has registered a view yet.
Checked as part of
- “In the Alliance A071801 randomized phase 3 trial of 242 patients with resected large brain metastases, three-to-five-session radiosurgery improved one-year...” · 1 claim · 29 September 2026
Evidence for
-
From Fractionated Radiosurgery Reduces Cancer Recurrence After Surgery for Large Brain Metastases Read 2026-09-29 Relevance DIRECT Steps 0 Counted
-
From Multi-fraction radiation significantly improves local control for large brain metastases Read 2026-09-29 Relevance STRONG Steps 0 Counted
-
From Fractionated Radiosurgery Reduces Cancer Recurrence After Surgery for Large Brain Metastases Read 2026-09-29 Relevance DIRECT Steps 0 Counted
Evidence against
None.
Qualifications
None.
Suppressed as dependent
| Evidence | Group | Kept instead |
|---|---|---|
| b71b3cf3 | 6b6500c0 |
Inferences
Concluded from
None.
Used as a premise in
None.
Threads
None. Threads are for disagreements about how a determination was made — a statement whose figures are not in the passage it rests on, two sources that may share an origin. Something about the world belongs in the evidence above.
Claim edges
None. Edges are stored and displayed; v0.1 does not propagate probability across them.
Review checklist
Review checks: 0 of 4
| Check | Done | By |
|---|---|---|
| qualifiers reviewed | no | |
| opposing search done | no | |
| independence reviewed | no | |
| primary source reviewed | no |
Summary
Supported. The main support is: The trial report gives 242 randomized patients, 87% versus 81% one-year surgical-bed control, and 29 versus 20 months median survival. e8d2c466
1 further item repeats the same origin and is not independent evidence. b71b3cf3
Review checks: 0 of 4. coverage:3d0f1151-a657-8336-9af5-c642c3599d58
Contribution history
| seq | event | detail |
|---|---|---|
| 19058 | APPENDED | |
| 19059 | ACCEPT | AUTOMATIC_AFTER_VALIDATION |
| 19066 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 19068 | LINK_EVIDENCE | by 1efd24fe (accepted) |
| 19097 | TASK_RESULT | by 1efd24fe (accepted) |